Literature DB >> 10369944

Attenuation correction in whole-body FDG oncological studies: the role of statistical reconstruction.

M Lonneux1, I Borbath, A Bol, A Coppens, M Sibomana, R Bausart, M Defrise, S Pauwels, C Michel.   

Abstract

Whole-body fluorine-18 fluoro-2-d-deoxyglucose positron emission tomography (FDG-PET) is widely used in clinical centres for diagnosis, staging and therapy monitoring in oncology. Images are usually not corrected for attenuation since filtered backprojection (FBP) reconstruction methods require a 10 to 15-min transmission scan per bed position on most current PET devices equipped with germanium-68 rod transmission sources. Such an acquisition protocol would increase the total scanning time beyond acceptable limits. The aim of this work is to validate the use of iterative reconstruction methods, on both transmission and emission scans, in order to obtain a fully corrected whole-body study within a reasonable scanning time of 60 min. Five minute emission and 3-min transmission scans are acquired at each of the seven bed positions. The transmission data are reconstructed with OSEM (ordered subsets expectation maximization) and the last iteration is reprojected to obtain consistent attenuation correction factors (ACFs). The emission image is then also reconstructed with OSEM, using the emission scan corrected for normalization, scatter and decay together with the set of consistent ACFs as inputs. The total processing time is about 35 min, which is acceptable in a clinical environment. The image quality, readability and accuracy of uptake quantification were assessed in 38 patients scanned for various malignancies. The sensitivity for tumour detection was the same for the non-attenuation-corrected (NAC-FBP) and the attenuation-corrected (AC-OSEM) images. The AC-OSEM images were less noisy and easier to interpret. The interobserver reproducibility was significantly increased when compared with non-corrected images (96.1% vs 81.1%, P<0.01). Standardized uptake values (SUVs) measured on images reconstructed with OSEM (AC-OSEM) and filtered backprojection (AC-FBP) were similar in all body regions except in the pelvic area, where SUVs were higher on AC-FBP images (mean increase 7.74%, P<0. 01). Our results show that, when statistical reconstruction is applied to both transmission and emission data, high quality quantitative whole-body images are obtained within a reasonable scanning (60 min) and processing time, making it applicable in clinical practice.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10369944     DOI: 10.1007/s002590050426

Source DB:  PubMed          Journal:  Eur J Nucl Med        ISSN: 0340-6997


  11 in total

1.  Effects of ROI definition and reconstruction method on quantitative outcome and applicability in a response monitoring trial.

Authors:  Nanda C Krak; R Boellaard; Otto S Hoekstra; Jos W R Twisk; Corneline J Hoekstra; Adriaan A Lammertsma
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-10-15       Impact factor: 9.236

2.  Evaluation of iterative reconstruction (OSEM) versus filtered back-projection for the assessment of myocardial glucose uptake and myocardial perfusion using dynamic PET.

Authors:  Hanne M Søndergaard; Mette Marie Madsen; Karin Boisen; Morten Bøttcher; Ole Schmitz; Torsten T Nielsen; Hans Erik Bøtker; Søren B Hansen
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-10-11       Impact factor: 9.236

3.  Adenocarcinoma of the esophagus and the esophagogastric junction: positron emission tomography improves staging and prediction of survival in distant but not in locoregional disease.

Authors:  Eero I T Sihvo; Jari V Räsänen; M Juhani Knuuti; Heikki R I Minn; Markku E S Luostarinen; Tapio Viljanen; Martti A Färkkilä; Jarmo A Salo
Journal:  J Gastrointest Surg       Date:  2004-12       Impact factor: 3.452

4.  Contribution of nonattenuation-corrected images on FDG-PET/CT in the assessment of solitary pulmonary nodules.

Authors:  Ertan Şahin; Ahmet Kara; Umut Elboğa
Journal:  Radiol Med       Date:  2016-08-27       Impact factor: 3.469

5.  Clinical evaluation of iterative reconstruction (ordered-subset expectation maximization) in dynamic positron emission tomography: quantitative effects on kinetic modeling with N-13 ammonia in healthy subjects.

Authors:  Jens D Hove; Rune Rasmussen; Jacob Freiberg; Søren Holm; Henning Kelbaek; Klaus E Kofoed
Journal:  J Nucl Cardiol       Date:  2008-04-16       Impact factor: 5.952

Review 6.  Methodological considerations in quantification of oncological FDG PET studies.

Authors:  Dennis Vriens; Eric P Visser; Lioe-Fee de Geus-Oei; Wim J G Oyen
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-11-20       Impact factor: 9.236

7.  Determination of tumour hypoxia with [18F]EF3 in patients with head and neck tumours: a phase I study to assess the tracer pharmacokinetics, biodistribution and metabolism.

Authors:  P Mahy; X Geets; M Lonneux; P Levêque; N Christian; M De Bast; J Gillart; D Labar; J Lee; V Grégoire
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-03-04       Impact factor: 9.236

8.  Radiation exposure during transmission measurements: comparison between CT- and germanium-based techniques with a current PET scanner.

Authors:  Tung-Hsin Wu; Yung-Hui Huang; Jason J S Lee; Shih-Yuan Wang; Su-Cheng Wang; Cheng-Tau Su; Liang-Kung Chen; Tieh-Chi Chu
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-10-08       Impact factor: 9.236

Review 9.  Attenuation-corrected vs. nonattenuation-corrected 2-deoxy-2-[F-18]fluoro-D-glucose-positron emission tomography in oncology: a systematic review.

Authors:  Urvi Joshi; Pieter G H M Raijmakers; Ingrid I Riphagen; Gerrit J J Teule; Arthur van Lingen; Otto S Hoekstra
Journal:  Mol Imaging Biol       Date:  2007 May-Jun       Impact factor: 3.488

10.  Quantitative performance and optimal regularization parameter in block sequential regularized expectation maximization reconstructions in clinical 68Ga-PSMA PET/MR.

Authors:  Edwin E G W Ter Voert; Urs J Muehlematter; Gaspar Delso; Daniele A Pizzuto; Julian Müller; Hannes W Nagel; Irene A Burger
Journal:  EJNMMI Res       Date:  2018-07-27       Impact factor: 3.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.